$CYTK Valuation Of Cytokinetics Shares Remain Attractive At These Levels, Says Roth Capital http://www.smarteranalyst.com/2014/08/01/cytokinetics-valuation-of-cytk-shares-remain-attractive-at-these-levels-says-roth-capital/